Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Nasal Packing Pain
NCT04519463Phase 1Unknown
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of lidocaine 10% oropharyngeal spray in epistaxis (2 arms). Primary endpoint: Visual Analogue Scale. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT04519463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04519463.